Melanoma
Conference Coverage
Adjuvant nivolumab plus ipilimumab shows strong results in resected stage IV melanoma
Results of German IMMUNED trial turn heads in advanced melanoma field.
Conference Coverage
Telltale dermoscopic features of melanomas lacking pigment reviewed
Investigators developed a simple, eight-variable model, which demonstrated a sensitivity of 70% and specificity of 56% for diagnosis of melanoma...
Commentary
Skin Cancer Management During the COVID-19 Pandemic
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome novel coronavirus 2 (SARS-CoV-2), has presented a...
Commentary
Skin Cancer Screening and Prevention During the COVID-19 Pandemic
It is important for dermatologists to maintain skin cancer screening and prevention efforts during the coronavirus disease 2019 pandemic.
Military Dermatology
Skin Cancer in the US Military
This review proposes education of individual military servicemembers regarding skin cancer prevention and identification, increasing the...
Article
How should we evaluate the benefit of immunotherapy combinations?
From the Journals
Phase 1 study: Beta-blocker may improve melanoma treatment response
“It’s exciting that an extremely inexpensive drug like propranolol that could be used in every country around the world could have an impact on...
Original Research
Mobile Apps for Professional Dermatology Education: An Objective Review
Mobile applications (apps) are a convenient way to learn dermatology, but there is no objective method to assess their quality. To determine which...
Original Research
Reliability of Biopsy Margin Status for Basal Cell Carcinoma: A Retrospective Study
The authors examined basal cell carcinoma biopsy specimens initially determined to have negative margins after routine sectioning and re-evaluated...
Conference Coverage
‘Impressive’ results with neoadjuvant T-VEC in advanced melanoma
Superior outcomes with intralesional T-VEC plus surgery persisted at 3 years.
Conference Coverage
Daily sunscreen use will prevent more melanoma deaths than early detection
“Prevention is low cost, low risk, and effective.”